Efficacy and Safety of Combination Therapy of Aliskiren/Amlodipine or Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Stage II Hypertension

NCT01070030 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

230

Enrollment

INDUSTRY

Sponsor class

Conditions

Stage II Hypertension

Interventions

DRUG: Aliskiren/Amlodipine (150/5 mg/day, 300/10 mg/day) , Aliskiren/Amlodipine/Hydrochlorothiazide (300/10/12.5 mg/day, 300/10/25 mg/day)

Sponsor

Novartis